NorthStar Asset Management (Massachusetts)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,204
Closed -$2.51M 57
2023
Q1
$2.51M Sell
16,204
-192
-1% -$31K 0.77% 34
2022
Q4
$2.9M Sell
16,396
-1
-0% -$173 0.97% 32
2022
Q3
$2.68M Buy
16,397
+349
+2% +$59.1K 0.93% 33
2022
Q2
$2.85M Buy
16,048
+168
+1% +$29.9K 0.94% 36
2022
Q1
$2.81M Sell
15,880
-607
-4% -$103K 0.77% 35
2021
Q4
$2.82M Buy
16,487
+159
+1% +$26K 0.71% 35
2021
Q3
$2.64M Sell
16,328
-6
-0% -$1.02K 0.7% 38
2021
Q2
$2.69M Buy
16,334
+5,698
+54% +$943K 0.72% 37
2021
Q1
$1.75M Buy
+10,636
New +$1.72M 0.55% 41

Other funds holding JNJ

NorthStar Asset Management (Massachusetts)'s JNJ Position: Q2 2023 in Review

NorthStar Asset Management (Massachusetts) sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 16,204 shares — an estimated $2.51M sold.

NorthStar Asset Management (Massachusetts) first reported a position in JNJ in Q1 2021 and held it in 9 quarters. The position peaked at $2.9M in Q4 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • NorthStar Asset Management (Massachusetts) reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • NorthStar Asset Management (Massachusetts) sold 16,204 Johnson & Johnson shares in Q2 2023, an estimated $2.51M.
  • NorthStar Asset Management (Massachusetts) first reported a position in Johnson & Johnson in Q1 2021 and held it in 9 quarters.
  • NorthStar Asset Management (Massachusetts)'s Johnson & Johnson position peaked at $2.9M in Q4 2022.
  • 3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on NorthStar Asset Management (Massachusetts)'s 13F filing for Q2 2023, filed 3 Aug 2023.